PLx Pharma Winddown Corp.

DB:1D5A Stock Report

Market Cap: €5.4k

PLx Pharma Winddown Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Pat Lonergan

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure5.7yrs

Recent management updates

Recent updates

CEO

Pat Lonergan (88 yo)

no data

Tenure

Mr. Patrick M. Lonergan, also known as Pat, co-founded Numark Laboratories Inc. in 1987 and has been its President since January 1989. Mr. Lonergan serves as Member of Chief Executive Officer Advisory Grou...

Board Members

NamePositionTenureCompensationOwnership
Michael Valentino
Chairman12.1yrsUS$393.75k1.7%
€ 91.0
Kirk Calhoun
Independent Director7.8yrsUS$55.00k0.0057%
€ 0.3
Todd Rosengart
Member of Scientific Advisory Board5.7yrsno datano data
Robert Casale
Independent Director7.5yrsUS$75.50k0.0093%
€ 0.5
Gary Balkema
Independent Director7.5yrsUS$50.00k0.019%
€ 1.0
P. Steg
Member of Scientific Advisory Board5.7yrsno datano data
Deepak Bhatt
Member of Scientific Advisory Board5.7yrsno datano data
Byron Cryer
Member of Scientific Advisory Board5.7yrsno datano data
Jayne Prats
Member of Scientific Advisory Board5.7yrsno datano data
Efthymios Deliargyris
Member of Scientific Advisory Board3.3yrsUS$801.65kno data
Dominick Angiolillo
Member of Scientific Advisory Board5.7yrsno datano data
Carey Kimmelstiel
Member of Scientific Advisory Board5.7yrsno datano data

5.7yrs

Average Tenure

66.5yo

Average Age

Experienced Board: 1D5A's board of directors are considered experienced (5.7 years average tenure).